We will continue to study the model system of murine induced thymic lymphomas by carcinogenic agents. Since we have already demonstrated that K and N-ras oncogenes are consistently associated with these tumors, we will concentrate first in the analysis of the balance or imbalance between the mutated, allele and its normal counteerpart in these tumors. We will study also the structure of the mouse N-ras oncogene determining the number and location of its untranslated exons and their function using in vitro mutagenesis and gene transfer. We will approach the controversial problem of ras being an early or late event in tumorigenesis by using transplantation of preleukemic cells from a single donor into several recipients and analyzing if the subseqent tumors have all the same oncogene mutation. Finally, and conceptually related to the previous experiments we will attempt to create transgenic mice with an activated N-ras oncogene, under the influence of an inducible promoter, to determine if it can, alone or in combination with other factors, produce malignancies when it is timely induced to express.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036327-08
Application #
3173883
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1984-01-01
Project End
1991-12-31
Budget Start
1991-01-01
Budget End
1991-12-31
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Lynch, Stephen J; Zavadil, Jiri; Pellicer, Angel (2014) In TCR-stimulated T-cells, N-ras regulates specific genes and signal transduction pathways. PLoS One 8:e63193
Benet, Marta; Dulman, Robin Yates; Suzme, Raffi et al. (2012) Wild type N-ras displays anti-malignant properties, in part by downregulating decorin. J Cell Physiol 227:2341-51
Osei-Sarfo, Kwame; de Castro, Ignacio Perez; Pellicer, Angel (2012) p15(INK4b) plays a crucial role in murine lymphoid development and tumorigenesis. Carcinogenesis 33:708-13
Osei-Sarfo, K; Martello, L; Ibrahim, S et al. (2011) The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral. Oncogene 30:3661-71
Perez de Castro, Ignacio; Benet, Marta; Jimenez, Maria et al. (2005) Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation. Cancer Res 65:3249-56
Diaz, Roberto; Lue, Jeffrey; Mathews, Jeremy et al. (2005) Inhibition of Ras oncogenic activity by Ras protooncogenes. Int J Cancer 113:241-8
Perez de Castro, Ignacio; Bivona, Trever G; Philips, Mark R et al. (2004) Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol 24:3485-96
Diaz, Roberto; Lopez-Barcons, Lluis; Ahn, Daniel et al. (2004) Complex effects of Ras proto-oncogenes in tumorigenesis. Carcinogenesis 25:535-9
Corral, Teresa; Jimenez, Maria; Hernandez-Munoz, Inmaculada et al. (2003) NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity. J Cell Physiol 197:214-24
Perez de Castro, Ignacio; Diaz, Roberto; Malumbres, Marcos et al. (2003) Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res 63:1615-22

Showing the most recent 10 out of 68 publications